AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government. The investment, announced last year in the Tories' spring budget ...

NEW YORK, NY / ACCESS Newswire / February 3, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn ...

LONDON, Jan 31 (Reuters) - AstraZeneca (AZN.L), opens new tab on ... "Following discussions with the current government, we are no longer pursuing our planned investment at Speke," a spokesperson ...

The positive recommendation from NICE for osimertinib was based on results from the ADAURA Phase III trial. In which, adjuvant treatment (after surgery) with osimertinib in patients with stage II ...

UBS analyst Matthew Weston maintained a Hold rating on AstraZeneca (AZN – Research Report) today and set a price target of p11,500.00. The company’s shares opened today at p11,242.00.

The existing facility will continue to operate and no jobs are at risk. The government said a “change in the make-up of the investment” proposed by AstraZeneca, which is headquartered in ...

An AstraZeneca spokesman said: “Following protracted discussions with the Government, we are no longer pursuing our planned investment at Speke. “Several factors have influenced this decision ...

A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to address concerns over its business in China than on its earnings report alone.

An AstraZeneca and Daiichi Sankyo drug designed to replace chemotherapy was cleared by US regulators for broader use in late-stage breast cancer patients. The Food and Drug Administration ...

BRITISH pharmaceutical giant AstraZeneca said on Friday (Jan 31 ... “Following protracted discussions with the government, we are no longer pursuing our planned investment” for Speke in Liverpool, ...

Confirming the reversal on Friday, a spokesperson for AstraZeneca said: "Following discussions with the current Government, we are no longer pursuing our planned investment in Speke. "Several factors ...

Select listed pharmaceuticals companies including Pfizer Ltd, Novartis India Ltd, AstraZeneca Pharma India Ltd and GSK Pharmaceuticals Ltd shall be the beneficiaries of the budget announcements ...